Thomas Smith

Stock Analyst at Leerink Partners

(1.82)
# 1494
Out of 5,441 analysts
103
Total ratings
Success rate
Average return
36 Stocks
Name Action PT Current % Upside Ratings Updated
EQ Equillium
Downgrades: Market Perform
3 1
n/a n/a 4 Mar 28, 2025
QTTB Q32 Bio
Downgrades: Market Perform
68 9
1.79 402.79% 2 Dec 11, 2024
ACRS Aclaris Therapeutics
Upgrades: Outperform
2 7
1.64 326.83% 7 Nov 19, 2024
ALMS Alumis
Initiates Coverage On: Outperform
29
4.34 568.2% 1 Jul 23, 2024
RNAC Cartesian Therapeuti...
Initiates Coverage On: Outperform
39
11 254.55% 1 Apr 23, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
42 65
64.97 0.05% 2 Apr 12, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
26
8.72 198.17% 1 Mar 25, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
80
9.45 746.56% 2 Feb 21, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
33
32.48 0.06% 2 Feb 20, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
20
69.02 -71.02% 1 Nov 14, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
30 17
16.87 0.77% 3 May 23, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
45 56
56.99 -1.74% 1 Mar 8, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
430 435
638.76 -31.9% 3 Mar 3, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Market Perform
17 18
19 -5.26% 7 Mar 3, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
36
58.61 -38.58% 1 Feb 28, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
9 7
2.06 239.81% 4 Feb 8, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
14 21
14.76 42.28% 6 Feb 6, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
40 45
16.9 166.27% 2 Jan 9, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
6
7.33 -18.14% 1 Nov 22, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
16 19
24.98 -23.94% 2 Nov 21, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Market Perform
30 20
22.93 -12.78% 4 Nov 11, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
5 6
3.42 75.44% 2 Nov 9, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
9 5
0.84 495.24% 3 Oct 21, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
46 77
47.55 61.93% 1 Oct 11, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
17
53.36 -68.14% 1 Aug 25, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
55 60
199.92 -69.99% 5 Aug 12, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
68 64
20.01 219.84% 2 Aug 9, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
66 70
17.1 309.36% 5 Aug 9, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
225 150
n/a n/a 5 Aug 3, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
50 29
8.76 231.05% 5 Jul 11, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
33 26
2.71 859.41% 3 Jun 1, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Market Perform
13 12
n/a n/a 4 May 12, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
18 12
38.19 -68.58% 2 Apr 28, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
15 10
3.78 164.55% 4 Apr 11, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
675 400
3.38 11734.32% 2 Mar 16, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
42 80
13.35 499.25% 2 Dec 8, 2020